Age-associated accumulation of the apolipoprotein C-III gene T-455C polymorphism C allele in a russian population

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 1, 2001, Pages B27-B32

  Anisimov, Sergey V ^a   Volkova, Maria V ^a,b   Lenskaya, Lilia V ^c   Khavinson, Vladimir K ^d   Solovieva, Dina V ^d   Schwartz, Eugene I ^a,b  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^c City Geriatric Centre   (Russian Federation)

^d St Petersburg Institute of Bioregulation and Gerontology   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3;

AGED; AGING; ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; LIPID METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; RUSSIAN FEDERATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CHILD; DNA; GENETICS, POPULATION; HUMANS; LONGEVITY; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RISK FACTORS; RUSSIA; TRIGLYCERIDES;

EID: 0035160239     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.1.B27     Document Type: Article

References (33)

1. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins
2. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
3. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia
4. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
5. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice
6. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms
7. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian schoolchildren
8. Promoter elements and factors required for hepatic and intestinal transcription of the human ApoCIII gene
9. Signal transduction convergence: Phorbol esters and insulin inhibit phospoenolpyruvate carboxykinase gene transcription through the same 10-base-pair sequence
10. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
11. Regulation of apolipoprotein CIII gene transcription by insulin: Characterization of an insulin response element in the CIII promoter
12. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
13. Prospective anaysis of the insulin-resistance syndrome (syndrome X)
14. Genetic basis of lipoprotein disorders
15. Hemodynamic actions of insulin
16. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
17. Molecular mechanisms of insulin resistance in arterial hypertension
18. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
19. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
20. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
21. Increased risk for endogenous hypertrigliceridemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism
22. Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population
23. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease
24. DNA polymorphism in the region of APOB 100, APOCIII, APOE, and angiotensin-converting enzyme genes and indicators of the lipid spectrum in children and adolescents in St. Petersburg
25. Apolipo protein CIII polymorphism and coronary heart disease
26. Allele-specific differences in apolipoprotein C-III mRNA expression in human liver
27. Cholesterol metabolism and colon cancer
28. Risk factors for malignant diseases: A cohort study on a population of 22,946 Icelanders
29. Regulation of gene expression by insulin
30. Biodemographic trajectories of longevity
31. Genes, demography, and life span: The contribution of demographic data in genetic studies on aging and longevity
32. Simple non-radioactive method of analysis of polymorphic markers flanking human apolipoprotein C-III gene